[go: up one dir, main page]

NO984299L - Anvendelse av antiarrytmiske forbindelser for nedsettelse av d°d etter infarkt - Google Patents

Anvendelse av antiarrytmiske forbindelser for nedsettelse av d°d etter infarkt

Info

Publication number
NO984299L
NO984299L NO984299A NO984299A NO984299L NO 984299 L NO984299 L NO 984299L NO 984299 A NO984299 A NO 984299A NO 984299 A NO984299 A NO 984299A NO 984299 L NO984299 L NO 984299L
Authority
NO
Norway
Prior art keywords
infarction
reduce
antiarrhythmic compounds
antiarrhythmic
compounds
Prior art date
Application number
NO984299A
Other languages
English (en)
Other versions
NO984299D0 (no
Inventor
Gurald Frangin
Alain Munoz
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of NO984299D0 publication Critical patent/NO984299D0/no
Publication of NO984299L publication Critical patent/NO984299L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO984299A 1996-03-18 1998-09-17 Anvendelse av antiarrytmiske forbindelser for nedsettelse av d°d etter infarkt NO984299L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9603357A FR2746013B1 (fr) 1996-03-18 1996-03-18 Utilisation de composes antiarythmiques dans la prevention de la mortalite post infarctus
PCT/FR1997/000474 WO1997034597A1 (fr) 1996-03-18 1997-03-17 Utilisation de composes antiarythmiques dans la reduction de la mortalite post infarctus

Publications (2)

Publication Number Publication Date
NO984299D0 NO984299D0 (no) 1998-09-17
NO984299L true NO984299L (no) 1998-11-17

Family

ID=9490276

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984299A NO984299L (no) 1996-03-18 1998-09-17 Anvendelse av antiarrytmiske forbindelser for nedsettelse av d°d etter infarkt

Country Status (14)

Country Link
US (1) US5985915A (no)
EP (1) EP0796617A1 (no)
JP (1) JP3253092B2 (no)
KR (1) KR20000064760A (no)
CN (1) CN1213965A (no)
AU (1) AU719358B2 (no)
CA (1) CA2249481A1 (no)
FR (1) FR2746013B1 (no)
HU (1) HUP9902580A3 (no)
IL (1) IL125980A0 (no)
NO (1) NO984299L (no)
NZ (1) NZ331931A (no)
WO (1) WO1997034597A1 (no)
ZA (1) ZA972340B (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5785995A (en) * 1997-04-11 1998-07-28 Upsher-Smith Laboratories, Inc. Pharmaceutical tablet of amiodarone salt
FR2764800B1 (fr) * 1997-06-23 1999-09-10 Sanofi Sa Composition pharmaceutique solide contenant des derives de benzofuranne
US6583198B2 (en) 1997-11-28 2003-06-24 Hitachi Chemical Company, Ltd. Photo curable resin composition and photosensitive element
DE19820151A1 (de) * 1998-05-06 1999-11-11 Hexal Ag Transdermales therapeutisches System zur Anwendung von Candesartan
US6517871B1 (en) * 1998-07-20 2003-02-11 Smithkline Beecham Corporation Bioenhanced formulations comprising eprosartan in oral solid dosage form
DE69923464T2 (de) 1998-09-10 2006-05-11 Sanofi-Aventis Deutschland Gmbh Benzenesulfonamide derivate in kombination mit beta-blockern zur behandlung von störungen des autonomen nervensystems
AU1157500A (en) * 1998-11-06 2000-05-29 Boehringer Ingelheim International Gmbh Medicaments based on combinations of lacidipine and telmisartan or of physiological derivatives thereof
DE60045211D1 (de) 1999-02-19 2010-12-23 Takeda Pharmaceutical Präparationen zur perkutanen aufnahme von zusammnesetzungen die einen angiotensin-ii-rezeptorantagonismus aufweisen
EA003052B1 (ru) * 1999-07-27 2002-12-26 Балканфарма Холдинг АД Антиаритмическое лекарственное средство
FR2817750B1 (fr) 2000-12-11 2003-02-21 Sanofi Synthelabo Composition pharmaceutique de dronedarone pour administration parenterale
US7413751B2 (en) * 2001-10-25 2008-08-19 Depomed, Inc. Methods of treatment using a gastric retained losartan dosage
EG24716A (en) * 2002-05-17 2010-06-07 Novartis Ag Combination of organic compounds
RU2212236C1 (ru) * 2002-09-05 2003-09-20 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Антиаритмическая, антиангинальная фармацевтическая композиция
US20060240086A1 (en) * 2003-07-31 2006-10-26 Tetsuro Tateishi Adhesive patch
EP1750862B1 (en) 2004-06-04 2011-01-05 Teva Pharmaceutical Industries Ltd. Pharmaceutical composition containing irbesartan
GB0719180D0 (en) 2007-10-02 2007-11-14 Cambrex Karlskoga Ab New process
JP2011518785A (ja) * 2008-04-17 2011-06-30 サノフイ−アベンテイス 心血管入院または死亡の予防に用いる薬剤を調製するためのドロネダロンの使用
FR2930149B1 (fr) * 2008-04-17 2011-02-18 Sanofi Aventis Association de dronedarone avec au moins un diuretique, son application en therapeutique
FR2930148A1 (fr) * 2008-04-17 2009-10-23 Sanofi Aventis Sa Utilisation de la dronedarone pour la preparation d'un medicament destine a la prevention de l'hospitalisation cardiovasculaire ou de la mortalite
EP2116239A1 (en) * 2008-04-29 2009-11-11 Sanofi-Aventis Method for managing the risks associated with an increase in serum creatinine during dronedarone treatment
WO2011135581A2 (en) * 2010-04-28 2011-11-03 Cadila Healthcare Limited Pharmaceutical compositions of dronedarone
US8602215B2 (en) 2010-06-30 2013-12-10 Sanofi Methods for reducing the risk of an adverse dronedarone/beta-blockers interaction in a patient suffering from atrial fibrillation
EP2431033A1 (en) 2010-08-10 2012-03-21 Sanofi Dronedarone for preventing cardiovascular hospitalization or mortality in patients with lone atrial fibrillation
WO2012020377A1 (en) 2010-08-11 2012-02-16 Sanofi Use of dronedarone for the preparation of a medicament for rhythm- and rate-controlling in patients with atrial fibrillation
US20130116586A1 (en) 2011-07-07 2013-05-09 Sanofi Use of dronedarone or a pharmaceutically acceptable salt thereof for the preparation of a drug for the prevention of atrial fibrillation
WO2013024411A1 (en) 2011-08-12 2013-02-21 Lupin Limited Co-milled formulation of dronedarone
CN102526469B (zh) * 2012-02-16 2013-07-10 罗群 一种用于心梗后康复的复方药物及其制备方法
EP2674158B9 (en) * 2012-06-14 2015-11-18 Szegedi Tudományegyetem Treatment and prevention of cardiac arrhythmias
CN104414970A (zh) * 2013-09-10 2015-03-18 成都力思特制药股份有限公司 一种盐酸胺碘酮注射液及其制备方法
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists
CN107753439A (zh) * 2016-08-22 2018-03-06 黑龙江迪龙制药有限公司 一种注射用盐酸胺碘酮及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2550091B1 (fr) * 1983-08-02 1986-05-23 Sanofi Sa Composition pharmaceutique ou veterinaire destinee a combattre des troubles ischemiques cardiaques contenant un derive du benzofuranne
FR2626176A1 (fr) * 1988-01-25 1989-07-28 Baligadoo Soorianarain Preparations medicamenteuses cardioprotectrices comprenant l'amiodarone un derive nitre, et facultativement un beta-bloqueur
US5252600A (en) * 1988-01-25 1993-10-12 Soorianarain Baligadoo Synergistic compositions for the treatment of coronary insufficiency and methods of use thereof
FR2665444B1 (fr) * 1990-08-06 1992-11-27 Sanofi Sa Derives d'amino-benzofuranne, benzothiophene ou indole, leur procede de preparation ainsi que les compositions les contenant.
WO1995009625A1 (en) * 1993-10-04 1995-04-13 Handforth Investments Ltd. Use of amiodarone for the treatment of heart failure

Also Published As

Publication number Publication date
JPH11507063A (ja) 1999-06-22
AU2296297A (en) 1997-10-10
NZ331931A (en) 2000-08-25
IL125980A0 (en) 1999-04-11
HUP9902580A3 (en) 2001-08-28
EP0796617A1 (fr) 1997-09-24
CN1213965A (zh) 1999-04-14
FR2746013B1 (fr) 1998-05-29
ZA972340B (en) 1998-09-18
JP3253092B2 (ja) 2002-02-04
WO1997034597A1 (fr) 1997-09-25
US5985915A (en) 1999-11-16
CA2249481A1 (fr) 1997-09-25
NO984299D0 (no) 1998-09-17
KR20000064760A (ko) 2000-11-06
HUP9902580A2 (hu) 2001-05-28
AU719358B2 (en) 2000-05-04
FR2746013A1 (fr) 1997-09-19

Similar Documents

Publication Publication Date Title
NO984299L (no) Anvendelse av antiarrytmiske forbindelser for nedsettelse av d°d etter infarkt
EE9900259A (et) Ühendi uus vorm
HU9702036D0 (en) New heterocyclic compounds as inhibitors of leucocita-adhesion and wla-4-antagonists
PL333918A1 (en) Derivatives of 6-phenylpyryidil-2-amine useful as nos inhibitors
EP1005343A4 (en) USE OF CSAIDS AS ANGIOGENESIS INHIBITORS
NO984290D0 (no) Farmas°ytisk nyttige forbindelser
DK0839806T3 (da) Substituerede tricykliske forbindelser
ATE198889T1 (de) Apolipoprotein-b syntheseinhibitoren
EE9800430A (et) Uued ühendid
DE69700310D1 (de) Rostschutzzusammensetzung
ID18446A (id) Proses untuk isomerisasi hidrokarbon-hidrokarbon alkilaromatik
ID17561A (id) Komposisi untuk pemakaian luar
ID22060A (id) Senyawa-senyawa 2-imidazolinilaminobenzoksazol berguna sebagai agonis adrenoseptor
ID19679A (id) Senyawa furan nitron
NO990832D0 (no) Syntese av bisendolylmalimider
ID16838A (id) Komposisi dekafluoropentana
AU4945697A (en) Solid phase synthesis of heterocyclic compounds
ID17424A (id) Penghambat matriks metaloproteasa oleh senyawa-senyawa fenetil tersubstitusi
ID17419A (id) Komposisi dekafluoropentana
IS4932A (is) Ný efnasambönd
ID16434A (id) Senyawa-senyawa 1,4-dihidropiridin
FI991343A7 (fi) Dihydropolyprenolien öljykoostumus
DE69733921D1 (de) Stämme der Biefhefe
KR970055602U (ko) 직냉식 냉장고용 냉각파이프 고정구조
GB9722054D0 (en) Pharmaceutical composition for the management of peptic ulcer conditions

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application